Lv4
640 积分 2021-12-27 加入
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases
3天前
已完结
Duration of Immunotherapy in dMMR/MSI-H Metastatic Colorectal Cancer Patients
6天前
已完结
First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study
8天前
已完结
Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603)
14天前
已完结
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
22天前
已完结
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis
23天前
已完结
DNA Checkpoint Gene Mutation as a Biomarker for Immune Checkpoint Inhibitor Therapy in Advanced Biliary Tract Cancer
24天前
已完结
Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes
28天前
已完结
Phase I study of trifluridine/tipiracil (TAS-102) plus irinotecan in combination with bevacizumab as a second-line therapy for patients with metastatic colorectal cancer
29天前
已完结
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma
29天前
已完结
皖公网安备34019202002308
